Related Experiment Video
Updated: May 6, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Tracheomalacia is associated with lower FEV1 and Pseudomonas acquisition in children with CF
Anthony J Fischer1, Sachinkumar B Singh, Ryan J Adam
1Department of Pediatrics, University of Iowa, Iowa City, Iowa.
Insights
Tracheomalacia (TM) is more common in children with cystic fibrosis (CF) than the general population. This condition increases the risk of airway obstruction and earlier Pseudomonas aeruginosa infection in CF patients.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
- Genetics and Genomics
Background:
- Tracheomalacia (TM) affects approximately 1 in 2,100 children.
- Abnormal tracheal development in cystic fibrosis (CF) animal models suggests a potential link to TM in children with CF.
Purpose of the Study:
- To determine the prevalence of TM in children with CF.
- To investigate the clinical impact and consequences of TM on CF patient outcomes.
Main Methods:
- A longitudinal study of children with CF born between 1995 and 2012.
- TM diagnosis based on dynamic tracheal collapse during bronchoscopy.
- Assessment of TM's effect on FEV1, CT scan findings, and pathogen acquisition.
Main Results:
- 15% of children with CF (15/97) showed TM on bronchoscopy.
- TM was associated with meconium ileus (P=0.003) and pancreatic insufficiency.
- Pseudomonas aeruginosa infection occurred 1.3 years earlier in children with TM (P=0.01).
- FEV1 at age 8 was over 18% lower in patients with TM.
- 3 of 15 patients with CF and TM experienced life-threatening airway obstruction, including one fatality.
Conclusions:
- TM is significantly more prevalent in children with CF compared to the general population.
- TM is linked to increased risk of airway obstruction and earlier acquisition of Pseudomonas aeruginosa in CF patients.
Background:
Tracheomalacia (TM) occurs in approximately 1 in 2,100 children. Because the trachea develops abnormally in animal models of cystic fibrosis (CF), we hypothesized this may also occur in children with CF, increasing their risk of TM.
Purpose:
To examine the prevalence and clinical consequences of TM in children with CF.
Methods:
We studied children with CF born between 1995 and 2012. TM was defined as dynamic collapse of the trachea, and the severity was recorded as described in the chart. The effect of TM on patient outcomes, including FEV1 , CT changes, and acquisition of CF pathogens, was assessed using a longitudinal patient dataset.
Results:
Eighty-nine percent of children with CF had at least one bronchoscopy (n = 97/109). Fifteen percent of these children had TM described in any bronchoscopy report (n = 15/97). Of the patients with TM, eight had meconium ileus (P = 0.003) and all were pancreatic insufficient. Pseudomonas aeruginosa infection occurred 1.3 years earlier among children with TM (P = 0.01). Starting FEV1 values by age 8 were diminished by over 18% of predicted for patients with TM. Life-threatening episodes of airway obstruction occurred in 3 of 15 patients with CF and TM, including one leading to death. Gender, prematurity, and hepatic disease were not associated with TM. No difference was observed in the frequency of bronchiectasis.
Conclusions:
TM is significantly more common in infants and children with CF than in the general population and is associated with airway obstruction and earlier Pseudomonas acquisition.
Related Concept Videos
Microbiota of the Respiratory Tract
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Atypical Pneumonia
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

